Our molecular and genome-wide characterization of VprBP using colon and prostate cancer cells indicate that VprBP overexpression and consequent H2AT120p downregulate a group of growth-regulatory genes, suggesting its direct contribution to epigenetic gene silencing and cancer pathogenesis [7,8]. This evidence concerns the gene DCAF1 and prostate cancer.